Table 1.

Baseline characteristics of COVID-19 patients at admission

	Total (n = 75)	Non-survivals (n = 9)	Survivals (n = 63)	p value*
Age, years	58.8 ± 14.9	72.4 ± 10.1	57.0 ± 14.5	0.003
Gender, male (n, %)	35 (46.7%)	6 (66.7%)	29 (43.9%)	0.29
Comorbidities (n, %)	34 (45.3%)	6 (66.7%)	28 (42.4%)	0.29
WBC (109/L)	6.41 ± 2.06	7.81 ± 2.26	6.21 ± 1.97	0.03
Lym (109/L)	1.41 ± 0.62	0.85 ± 0.55	1.49 ± 0.59	0.003
PLT (109/L)a	255.5 (199.3, 322.5)	206.0 (160.5, 299.0)	259.0 (205.5, 323.0)	0.12
BUN (mmol/L)a	4.30 (3.40, 5.70)	7.70 (5.05, 21.20)	4.10 (3.18, 5.25)	0.002
Creatinine (µmol/L)a	70.0 (53.0, 82.0)	110.0 (59.5, 188.0)	65.0 (52.0, 79.3)	0.04
TB (µmol/L)a	7.9 (6.6, 11.5)	9.8 (7.3, 13.4)	7.7 (6.6, 11.4)	0.20
INRa	1.07 (1.03, 1.12)	1.17 (1.05, 1.28)	1.07 (1.01, 1.10)	0.04
d-dimer (µg/mL FEU)a	0.48 (0.22, 1.43)	2.16 (1.52, 9.69)	0.43 (0.22, 1.15)	< 0.001
NT-proBNP (pg/mL)a	96.0 (36.0, 207.0)	943.0 (262.5, 2539.0)	67.0 (29.3, 163.8)	< 0.001
TnI (pg/mL)a	2.60 (1.90, 7.60)	24.60 (13.90, 65.00)	2.25 (1.90, 4.90)	< 0.001
CRP (mg/L)a	4.10 (0.80, 35.80)	119.70 (75.50, 144.50)	3.00 (0.70, 17.40)	< 0.001
Procalcitonin (ng/mL)a	0.06 (0.05, 0.09)	0.21 (0.14, 0.47)	0.06 (0.05, 0.07)	< 0.001
CK (µ/L)a	65.0 (43.5, 99.5)	188.0 (118.0, 296.0)	64.5 (42.0, 88.3)	0.001
LDH (µ/L)a	253.0 (183.0, 314.0)	465.0 (300.0, 576.0)	239.5 (174.8, 302.0)	< 0.001
Interleukin-6 (pg/mL)a	3.62 (1.54, 14.27)	63.13 (28.16, 125.45)	3.13 (1.50, 8.01)	< 0.001

WBC white blood cell counts, Lym lymphocyte counts, PLT platelet counts, BUN blood urea nitrogen, Cr creatinine, TB total bilirubin, INR international normalized ratio, NT-proBNP N-terminal pro-B-type natriuretic peptide, TnI troponin I, CRP c-reactive protein, CK creatine kinase, LDH lactate dehydrogenase

^*p values for the comparison of baseline characteristics between non-survivals and survivals. Student’s t test, Mann–Whitney U test or Fisher’s exact test according to the characteristics of distribution

^aMedian (interquartile range)